Essential Therapeutics, Pllc | |
5960 E Tinto St, Mesa, AZ 85215-0843 | |
(480) 720-0494 | |
Not Available |
Full Name | Essential Therapeutics, Pllc |
---|---|
Type | Facility |
Speciality | Occupational Therapist |
Location | 5960 E Tinto St, Mesa, Arizona |
Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1457655300 | NPI | - | NPPES |
Provider Name | Nicoletta Duvall |
---|---|
Provider Type | Practitioner - Occupational Therapist In Private Practice |
Provider Identifiers | NPI Number: 1366686479 PECOS PAC ID: 6305216797 Enrollment ID: I20230109002525 |
News Archive
Using existing drugs, such as lithium, to restore basic biological processes in human cells and animal models, researchers may have broken a long-standing logjam in devising effective treatments for human mitochondrial diseases.
Epigem, a high-tech British micro engineering company, is supporting research into Multiple Sclerosis (MS) with a new PhD programme to create a novel drug screening platform. This will accelerate the production of MS models and pre-clinical drug development, in order to understand better the disease process and its periods of remission.
A study led by researchers at Boston University School of Medicine provides novel insight into the impact that genes may have on Huntington's disease (HD). The study, published online in PLOS Genetics, identified specific small segments of RNA (called micro RNA or miRNA) encoded in DNA in the human genome that are highly expressed in HD.
The Michael J. Fox Foundation for Parkinson's Research has awarded a total of $2 million to five research teams carrying out clinical studies to refine understanding of postural instability and gait disturbances (PIGD) in Parkinson's disease, and help speed the development of urgently needed treatments.
› Verified 8 days ago
Provider Name | Timmery Perez |
---|---|
Provider Type | Practitioner - Occupational Therapist In Private Practice |
Provider Identifiers | NPI Number: 1982821096 PECOS PAC ID: 1850762378 Enrollment ID: I20230120000586 |
News Archive
Using existing drugs, such as lithium, to restore basic biological processes in human cells and animal models, researchers may have broken a long-standing logjam in devising effective treatments for human mitochondrial diseases.
Epigem, a high-tech British micro engineering company, is supporting research into Multiple Sclerosis (MS) with a new PhD programme to create a novel drug screening platform. This will accelerate the production of MS models and pre-clinical drug development, in order to understand better the disease process and its periods of remission.
A study led by researchers at Boston University School of Medicine provides novel insight into the impact that genes may have on Huntington's disease (HD). The study, published online in PLOS Genetics, identified specific small segments of RNA (called micro RNA or miRNA) encoded in DNA in the human genome that are highly expressed in HD.
The Michael J. Fox Foundation for Parkinson's Research has awarded a total of $2 million to five research teams carrying out clinical studies to refine understanding of postural instability and gait disturbances (PIGD) in Parkinson's disease, and help speed the development of urgently needed treatments.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Essential Therapeutics, Pllc 5960 E Tinto St, Mesa, AZ 85215-0843 Ph: (480) 720-0494 | Essential Therapeutics, Pllc 5960 E Tinto St, Mesa, AZ 85215-0843 Ph: (480) 720-0494 |
News Archive
Using existing drugs, such as lithium, to restore basic biological processes in human cells and animal models, researchers may have broken a long-standing logjam in devising effective treatments for human mitochondrial diseases.
Epigem, a high-tech British micro engineering company, is supporting research into Multiple Sclerosis (MS) with a new PhD programme to create a novel drug screening platform. This will accelerate the production of MS models and pre-clinical drug development, in order to understand better the disease process and its periods of remission.
A study led by researchers at Boston University School of Medicine provides novel insight into the impact that genes may have on Huntington's disease (HD). The study, published online in PLOS Genetics, identified specific small segments of RNA (called micro RNA or miRNA) encoded in DNA in the human genome that are highly expressed in HD.
The Michael J. Fox Foundation for Parkinson's Research has awarded a total of $2 million to five research teams carrying out clinical studies to refine understanding of postural instability and gait disturbances (PIGD) in Parkinson's disease, and help speed the development of urgently needed treatments.
› Verified 8 days ago
Sarah Ashley Miller, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5210 E Hampton Ave, Apt 2127, Mesa, AZ 85206 Phone: 301-641-7433 | |
Mary Ann Sheely, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 930 W Southern Ave, Ste 10, Mesa, AZ 85210 Phone: 480-835-0857 Fax: 480-898-0138 | |
Robert C Stidham Ii, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2919 S Ellsworth Rd, Suite 111, Mesa, AZ 85212 Phone: 704-831-5065 | |
Mrs. Rebecca Hughes, OTR Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 6124 E Brown Rd, Ste. 102, Mesa, AZ 85205 Phone: 480-497-3285 Fax: 480-833-2513 | |
Maggie Miller, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1025 N Country Club Dr, Mesa, AZ 85201 Phone: 623-606-6355 | |
Samantha Klassen, OTR-L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 551 S Higley Rd, Mesa, AZ 85206 Phone: 480-892-9777 Fax: 480-635-0222 | |
Shelley Wilson, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 551 S Higley Rd, Mesa, AZ 85206 Phone: 480-892-9777 |